AtriCure, Inc.
ATRC
$32.41
-$0.305-0.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.53% | 7.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.53% | 7.22% | |||
| Cost of Revenue | -2.10% | 8.73% | |||
| Gross Profit | 0.01% | 6.71% | |||
| SG&A Expenses | 5.36% | -1.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.65% | 12.56% | |||
| Operating Income | 59.00% | -96.12% | |||
| Income Before Tax | 57.47% | -103.19% | |||
| Income Tax Expenses | -10.15% | -17.39% | |||
| Earnings from Continuing Operations | 56.66% | -98.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 56.66% | -98.24% | |||
| EBIT | 59.00% | -96.12% | |||
| EBITDA | 91.03% | -291.48% | |||
| EPS Basic | 56.90% | -98.20% | |||
| Normalized Basic EPS | 57.71% | -103.10% | |||
| EPS Diluted | 56.90% | -98.20% | |||
| Normalized Diluted EPS | 57.71% | -103.10% | |||
| Average Basic Shares Outstanding | 0.57% | 0.04% | |||
| Average Diluted Shares Outstanding | 0.57% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||